Europe´s leading
cannabinoid company

We are consolidating the strongest player under one roof to make cannabinoids accessible.

Europe´s leading
cannabinoid company

We are consolidating the strongest player under one roof to make cannabinoids accessible.

About us

SynBiotic unlocks the power of cannabinoids to heal modern world diseases.

Chronic pain, stress and sleep issues affect the health and well-being of millions of people – proper solutions to these problems reflect multi-billion dollar markets.

Focus on real consumer problems.

People are looking for solutions to their real-life problems. With cannabinoids we are able to address a multi-billion EU-market for sleep, pain and anxiety solutions with cumulative sales of over € 250 billion for OTC and pharmaceuticals in 2020.

people with sleep-related problems, such as disturbed sleep

people with chronic pain and similar issues

people with anxiety and similar issues

introduction

SynBiotic unlocks the power of cannabinoids to heal modern world diseases.

Chronic pain, stress and sleep issues affect the health and well-being of millions of people – proper solutions to these problems reflect multi-billion dollar markets.

Learn how me make rich our clients with simple investing ideas

Learn how me make rich our clients with simple investing ideas

Learn how me make rich our clients with simple investing ideas

SynBiotic Value Chain

SynBiotic’s organizational structure is built to cover all value drivers – from research over production to distribution

Research & Development

Our R&D portfolio consists of leading research facilities, whose scientists are sought-after pioneers in the field of cannabinoids.

1

Production & Biotech

With a portfolio of production and extraction companies operating cutting-edge facilities, we can guarantee products of the highest quality – a significant competitive advantage.

2

Distribution

We buy and build strong medical & DTC brands which enable us to distribute our innovative products to customers.

3

Value Chain

SynBiotic’s organizational structure is built to cover all value drivers – from research over production to distribution

our structure includes

Research & Development

Our R&D portfolio consists of leading research facilities, whose scientists are sought-after pioneers in the field of cannabinoids.

Production & Biotech

With a portfolio of production and extraction companies operating cutting-edge facilities, we can guarantee products of the highest quality – a significant competitive advantage.

Distribution

We buy and build strong medical & DTC brands which enable us to distribute our innovative products to customers.

Approach

Beyond Cannabis for a multi-billion market.
Regulations, market, and customer readiness make CBD the most promising cannabinoid to start with, building a solid foundation for our platform. But we focus not solely on CBD and THC, but also on other cannabinoids, endocannabinoids and terpenes with high potential.

our reasearched cannabinoids

Why? – Because we want to build the most effective products in the market

Most CBX* have not been discovered yet, but studies show that other cannabinoids, beyond THC and CBD, have huge medical potential. In addition, the so called entourage effect is a term used to describe the synergistic effects of combining various chemical compounds found in cannabis. Most commonly, it refers to the interaction between THC/CBD and other cannabinoids or terpenes.
* CBX = all cannabinoids except THC

Responsive

Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur.

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae.

Consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur at vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti.

Molestias excepturi sint occaecati cupiditate non provident, similique sunt in culpa qui officia deserunt mollitia animi, id est laborum et dolorum fuga.

Our Companies

We cover with our buy & build strategy the whole value chain
and consolidate the strongest players in the industry under one roof.

See All
Hempamed
One of the Top 3 CBD brands in Germany
Solidmind
Group GmbH
Successful brand-builder in the wellbeing industry
BioCBD
One of the biggest marketplace for organic hemp & CBD products
Cannexo GmbH
Joint-venture with leading players in the pharma industry
GECA
Pharma GmbH
Import & distribution of medical cannabis products
Lean Labs
Pharma GmbH
CBD production & extraction company
based in Germany
NeuroTheryX
Canada LTD
AI-powered drug discovery platform.
GreenLight Pharmaceutical LTD
Plattform for clinical trial with cannabinoids

Who We Are

Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse varius enim in eros elementum tristique.

What Stage Are You In?

Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse varius enim in eros elementum tristique.

VENTURE

Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse varius enim in eros elementum tristique.

News

Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse varius enim in eros elementum tristique.

Newsroom

Be part of our Community

More than just your regular investing firm around

For Ventures

SynBiotic supports & invests in cannabinoid focused ventures and teams. Are you looking for a strong partner?

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum lorem eum fugiat quo voluptas nulla pariatur? At vero accusamus iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque.

For Investors

Find out more about our company, its structure, shares and download the latest financial publications.

Join Us. Apply Now

Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Suspendisse varius enim in eros elementum tristique.